Experiment: 2N5J

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
2	3D 1H-13C NOESY aliphatic	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
3	3D 1H-15N NOESY	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
4	3D HNCA	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
5	3D HN(CA)HA	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
6	3D HN(CO)CA	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
7	3D HNCO	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
8	3D C(CO)NH	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
9	3D CBCA(CO)NH	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
10	3D HNCACB	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
11	3D H(CCO)NH	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
12	2D 1H-13C HSQC aliphatic	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
13	2D 1H-13C HSQC aromatic	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298
14	3D 1H-13C NOESY aromatic	1.1 mM [U-99% 13C; U-99% 15N] Reg1_NTD-1, 5 ug DSS-2, 10% v/v [U-2H] D2O-3, 20 mM HEPES-4, 150 mM sodium chloride-5	90% H2O/10% D2O	170	6.8	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Agilent	INOVA	800
2	Agilent	INOVA	600
3	Agilent	INOVA	600

NMR Refinement
Method	Details	Software
distance geometry		VNMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR	6.1C	Varian
2	processing	NMRPipe	2008	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	Olivia		Masashi Yokochi
4	peak picking	Olivia		Masashi Yokochi
5	data analysis	Olivia		Masashi Yokochi
6	data analysis	TALOS		Cornilescu, Delaglio and Bax
7	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
8	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
9	processing	rnmrtk	v.3	JC Hoch and AS Sterm

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.